2023 Psychopharmacology Pearls

Registration Options

Activity Dates: 12/12/2023 - 06/14/2024

Target Audience

BCPPs who value and learn through case-based literature offering therapeutic advice based on both evidence and longstanding clinical experience are the target audience for this product. New and experienced BCPPs desiring insights into the strategies of clinical decision-making used by expert clinicians will find value in this product as the articles focus on disease states, their pharmacotherapy, and the synthesis of solutions to challenges that require judgement(s) founded on evidence but modified or tempered by extensive clinical experience and practicalities of “real world” necessities.

Content

This recertification product consists of four clinical review articles focused on single disorders, or on one or more distinct aspects of a single psychiatric, neurologic, or substance use disorder. Authored by leading experts in the field and hosted in AAPP’s peer-reviewed journal, The Mental Health Clinician (MHC), these case-based articles will be fully referenced and offer therapeutic advice based on both evidence and longstanding clinical experience. Pearls articles focus on aspects of disease states and their pharmacotherapy that require synthesis of solutions to problems or development of practices that require judgement(s) founded on evidence, but modified or tempered by extensive clinical experience and practicalities of “real world” necessities. The articles are intended to allow you to gain greater insights into the strategies of clinical decision-making used by expert clinicians.

• Four (4) articles in an electronic format.
• Five (5) hours of ACPE credit and 5 hours of BCPP Recertification credit achieved by successfully completing the online AAPP recertification examination. ACPE credit is reported to CPE Monitor at nabp.net within 48 hours after successful completion of the examination. BCPP Recertification credit is earned and reported within the year the assessment is successfully completed (2022 or 2023).
• Access to the AAPP testing center with exam submission due by June 12, 2024.

Consider making this product part of your BPS Continuing Professional Development plan! Please refer to the BPS Psychiatric Pharmacy Content Outline to see how this activity may align.

Course Requirements

To satisfactorily complete the Psychopharmacology Pearls and receive 5 hours of BCPP Recertification and ACPE credit, candidates must meet the following requirements:

1. Abide by a confidentiality and honesty statement requiring individual completion of the recertification education.
2. Successfully complete an online examination on or before the deadline of June 12, 2024.
3. Meet the minimum passing score on the final examination as determined by a panel of experts.
4. Partial credit is not available.
5. Learners who do not achieve a passing score on a post-activity assessment may appeal assessment questions and/or request a remediation assessment. View AAPP's Post-Activity Assessment Appeal and Remediation Policy.

You will proceed through the following steps to satisfactorily complete this course:

Faculty Information

Learning Objectives

Concepts for Selection and Utilization of Psychiatric Medications in Pregnancy

1. Provide patient education for psychiatric medication use during pregnancy.
2. Design a therapeutic plan for a pregnant patient experiencing a psychiatric illness.
3. Assess the evidence for the use of psychiatric medications in pregnant patients.

Concurrent Opioid and Alcohol Withdrawal Management

1. Create a measurement-based care monitoring plan to support individualized treatment of concurrent opioid and alcohol withdrawal.
2. Design a pharmacotherapy regimen for managing alcohol and opioid withdrawal concurrently.
3. Select MOUD and MAUD with goal of continuation after resolution of withdrawal.

Ethnopsychopharmacology: Clinical and Scientific Writing Pearls

1. Apply best practice recommendations for scientific writing as it relates to the use of race, ethnicity, and ancestry.
2. Describe how the safety and effectiveness of medications, such as, antidepressants and antipsychotics, may be impacted by a patient’s ancestry.
3. Recognize aspects of creating a pharmacotherapy plan that accounts for a patient’s ancestry.

Management of OFF Condition in Parkinson Disease

1. Adjust carbidopa/levodopa medication regimens for a given patient to mitigate motor fluctuations.
2. Evaluate augmentation strategies for a patient with Parkinson disease based upon patient-specific factors.
3. Select an on-demand therapy for a patient with Parkinson disease and an unpredictable OFF period.

Continuing Education Credit and Disclosures

The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Psychopharmacology Pearls product is an application-based program approved for 5 ACPE contact hours. To receive ACPE credit, pharmacists completing this programming are required to complete an evaluation of the course as well as pass an online examination.

Board Certified Psychiatric Pharmacists (BCPPs) may also receive 5 hours of BCPP Recertification Credit for the Psychopharmacology Pearls upon successful completion of an online examination.

The American Association of Psychiatric Pharmacists is approved as a Professional Development Provider for the Board Certified Psychiatric Pharmacist (BCPP) specialty by the Board of Pharmacy Specialties (BPS). This course is part of a 5 hour BCPP recertification product earned after successful completion of the associated BCPP recertification examination for the full product.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.